Carregant...

Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application

Pancreatic ductal adenocarcinoma (PDAC) is predicted to become the second leading cause of cancer-related mortality within the next decade, with limited effective treatment options and a dismal long-term prognosis for patients. Genomic profiling has not yet manifested clinical benefits for diagnosis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pancreatology
Autors principals: Sivapalan, L., Kocher, H.M., Ross-Adams, H., Chelala, C.
Format: Artigo
Idioma:Inglês
Publicat: Karger Publishers 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7994018/
https://ncbi.nlm.nih.gov/pubmed/33451936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pan.2020.12.017
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!